| Originalsprog | Engelsk |
|---|---|
| Publikationsdato | 2008 |
| Status | Udgivet - 2008 |
| Begivenhed | DSKO's Årsmøde - Vejle, Danmark Varighed: 10. apr. 2008 → 10. apr. 2008 |
Konference
| Konference | DSKO's Årsmøde |
|---|---|
| Land | Danmark |
| By | Vejle |
| Periode | 10/04/2008 → 10/04/2008 |
Citer dette
Spindler, K-L. G., & Jakobsen, A. (2008). The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer. Poster session præsenteret på DSKO's Årsmøde, Vejle, Danmark.
@conference{7d608670437711dd9fbe000ea68e967b,
title = "The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer",
author = "Spindler, {Karen-Lise Garm} and Anders Jakobsen",
year = "2008",
language = "English",
note = "null ; Conference date: 10-04-2008 Through 10-04-2008",
}
Spindler, K-LG & Jakobsen, A 2008, 'The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer', DSKO's Årsmøde, Vejle, Danmark, 10/04/2008 - 10/04/2008.
The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer. / Spindler, Karen-Lise Garm; Jakobsen, Anders.
2008. Poster session præsenteret på DSKO's Årsmøde, Vejle, Danmark.Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning
TY - CONF
T1 - The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer
AU - Spindler, Karen-Lise Garm
AU - Jakobsen, Anders
PY - 2008
Y1 - 2008
M3 - Poster
ER -
Spindler K-LG, Jakobsen A. The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer. 2008. Poster session præsenteret på DSKO's Årsmøde, Vejle, Danmark.